Biocon Ltd. NSE: BIOCON | BSE: 532523

Mid-range Performer

Download real time

349.40 -4.05 (-1.15%)

850.9K

NSE+BSE Volume

NSE 13 Oct, 2025 3:31 PM (IST)

US FDA Observation

Biocon's New Jersey manufacturing facility receives Form 483 with one observation from the US FDA See details

Biocon Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Biocon Ltd. from all sources in a single place.

Load latest

Is Biocon Ltd. worth buying?

728 Votes:

Buy 75.0%

Sell 16.35%

Hold 8.65%

RESEARCH REPORTS

Sell SEE REPORTS >

Buy SEE REPORTS >